BETAMETHASONE DIPROPRIONATE 0.05% / MINOXIDIL 7%- betamethasone diproprionate 0.05% / minoxidil 7% solution 
Sincerus Florida, LLC

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

----------

BETAMETHASONE DIPROPRIONATE 0.05% / MINOXIDIL 7%

Directions for use

fh

Sincerus Florida, LLC. Adverse reactions

X

Active, inactive

ss

NDC 72934-4025-8. BETAMETHASONE DIPROPRIONATE USP 0.05% / MINOXIDIL USP 7%. Solution 60 gm

zc

BETAMETHASONE DIPROPRIONATE 0.05% / MINOXIDIL 7% 
betamethasone diproprionate 0.05% / minoxidil 7% solution
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:72934-4025
Route of Administration TOPICAL
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
BETAMETHASONE DIPROPIONATE (UNII: 826Y60901U) (BETAMETHASONE - UNII:9842X06Q6M) BETAMETHASONE 0.05 g  in 100 g
MINOXIDIL (UNII: 5965120SH1) (MINOXIDIL - UNII:5965120SH1) MINOXIDIL 7 g  in 100 g
Product Characteristics
Color white (clear solution) Score     
Shape Size
Flavor Imprint Code
Contains     
Packaging
# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:72934-4025-8 60 g in 1 BOTTLE, GLASS; Type 0: Not a Combination Product 05/10/2019
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
unapproved drug other 05/10/2019
Labeler - Sincerus Florida, LLC (080105003)
Establishment
Name Address ID/FEI Business Operations
Sincerus Florida, LLC 080105003 manufacture(72934-4025)

Revised: 5/2019
Document Id: 8875a838-5a95-3407-e053-2a95a90ae3eb
Set id: 8875a838-5a94-3407-e053-2a95a90ae3eb
Version: 1
Effective Time: 20190509
 
Sincerus Florida, LLC